344 related articles for article (PubMed ID: 26348842)
1. Cortical Function in Asymptomatic Carriers and Patients With C9orf72 Amyotrophic Lateral Sclerosis.
Geevasinga N; Menon P; Nicholson GA; Ng K; Howells J; Kril JJ; Yiannikas C; Kiernan MC; Vucic S
JAMA Neurol; 2015 Nov; 72(11):1268-74. PubMed ID: 26348842
[TBL] [Abstract][Full Text] [Related]
2. Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis.
Vucic S; Nicholson GA; Kiernan MC
Brain; 2008 Jun; 131(Pt 6):1540-50. PubMed ID: 18469020
[TBL] [Abstract][Full Text] [Related]
3. Pathophysiological insights into ALS with C9ORF72 expansions.
Williams KL; Fifita JA; Vucic S; Durnall JC; Kiernan MC; Blair IP; Nicholson GA
J Neurol Neurosurg Psychiatry; 2013 Aug; 84(8):931-5. PubMed ID: 23463871
[TBL] [Abstract][Full Text] [Related]
4. Axonal ion channel dysfunction in c9orf72 familial amyotrophic lateral sclerosis.
Geevasinga N; Menon P; Howells J; Nicholson GA; Kiernan MC; Vucic S
JAMA Neurol; 2015 Jan; 72(1):49-57. PubMed ID: 25384182
[TBL] [Abstract][Full Text] [Related]
5. Cortical hyperexcitability and disease spread in amyotrophic lateral sclerosis.
Menon P; Geevasinga N; van den Bos M; Yiannikas C; Kiernan MC; Vucic S
Eur J Neurol; 2017 Jun; 24(6):816-824. PubMed ID: 28436181
[TBL] [Abstract][Full Text] [Related]
6. Cortical contributions to the flail leg syndrome: Pathophysiological insights.
Menon P; Geevasinga N; Yiannikas C; Kiernan MC; Vucic S
Amyotroph Lateral Scler Frontotemporal Degener; 2016; 17(5-6):389-96. PubMed ID: 26888565
[TBL] [Abstract][Full Text] [Related]
7. Phenotype difference between ALS patients with expanded repeats in C9ORF72 and patients with mutations in other ALS-related genes.
Millecamps S; Boillée S; Le Ber I; Seilhean D; Teyssou E; Giraudeau M; Moigneu C; Vandenberghe N; Danel-Brunaud V; Corcia P; Pradat PF; Le Forestier N; Lacomblez L; Bruneteau G; Camu W; Brice A; Cazeneuve C; Leguern E; Meininger V; Salachas F
J Med Genet; 2012 Apr; 49(4):258-63. PubMed ID: 22499346
[TBL] [Abstract][Full Text] [Related]
8. Cortical hyperexcitability in patients with C9ORF72 mutations: Relationship to phenotype.
Schanz O; Bageac D; Braun L; Traynor BJ; Lehky TJ; Floeter MK
Muscle Nerve; 2016 Aug; 54(2):264-9. PubMed ID: 26799151
[TBL] [Abstract][Full Text] [Related]
9. Frequency of C9orf72 repeat expansions in amyotrophic lateral sclerosis: a Belgian cohort study.
Debray S; Race V; Crabbé V; Herdewyn S; Matthijs G; Goris A; Dubois B; Thijs V; Robberecht W; Van Damme P
Neurobiol Aging; 2013 Dec; 34(12):2890.e7-2890.e12. PubMed ID: 23870417
[TBL] [Abstract][Full Text] [Related]
10. Defining the mechanisms that underlie cortical hyperexcitability in amyotrophic lateral sclerosis.
Vucic S; Cheah BC; Kiernan MC
Exp Neurol; 2009 Nov; 220(1):177-82. PubMed ID: 19716820
[TBL] [Abstract][Full Text] [Related]
11. Reduction in short interval intracortical inhibition from the early stage reflects the pathophysiology in amyotrophic lateral sclerosis: A meta-analysis study.
Higashihara M; Pavey N; Menon P; van den Bos M; Shibuya K; Kuwabara S; Kiernan MC; Koinuma M; Vucic S
Eur J Neurol; 2024 Jul; 31(7):e16281. PubMed ID: 38504632
[TBL] [Abstract][Full Text] [Related]
12. Cortical hyperexcitability evolves with disease progression in ALS.
Menon P; Higashihara M; van den Bos M; Geevasinga N; Kiernan MC; Vucic S
Ann Clin Transl Neurol; 2020 May; 7(5):733-741. PubMed ID: 32304186
[TBL] [Abstract][Full Text] [Related]
13. Cortical excitability testing distinguishes Kennedy's disease from amyotrophic lateral sclerosis.
Vucic S; Kiernan MC
Clin Neurophysiol; 2008 May; 119(5):1088-96. PubMed ID: 18313980
[TBL] [Abstract][Full Text] [Related]
14. Brain morphologic changes in asymptomatic C9orf72 repeat expansion carriers.
Walhout R; Schmidt R; Westeneng HJ; Verstraete E; Seelen M; van Rheenen W; de Reus MA; van Es MA; Hendrikse J; Veldink JH; van den Heuvel MP; van den Berg LH
Neurology; 2015 Nov; 85(20):1780-8. PubMed ID: 26497991
[TBL] [Abstract][Full Text] [Related]
15. A hexanucleotide repeat expansion in C9ORF72 causes familial and sporadic ALS in Taiwan.
Tsai CP; Soong BW; Tu PH; Lin KP; Fuh JL; Tsai PC; Lu YC; Lee IH; Lee YC
Neurobiol Aging; 2012 Sep; 33(9):2232.e11-2232.e18. PubMed ID: 22673113
[TBL] [Abstract][Full Text] [Related]
16. Riluzole exerts central and peripheral modulating effects in amyotrophic lateral sclerosis.
Vucic S; Lin CS; Cheah BC; Murray J; Menon P; Krishnan AV; Kiernan MC
Brain; 2013 May; 136(Pt 5):1361-70. PubMed ID: 23616585
[TBL] [Abstract][Full Text] [Related]
17. Cortical excitability distinguishes ALS from mimic disorders.
Vucic S; Cheah BC; Yiannikas C; Kiernan MC
Clin Neurophysiol; 2011 Sep; 122(9):1860-6. PubMed ID: 21382747
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic utility of cortical excitability studies in amyotrophic lateral sclerosis.
Geevasinga N; Menon P; Yiannikas C; Kiernan MC; Vucic S
Eur J Neurol; 2014 Dec; 21(12):1451-7. PubMed ID: 24698287
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the C9orf72 hexanucleotide repeat expansion in Korean patients with familial and sporadic amyotrophic lateral sclerosis.
Jang JH; Kwon MJ; Choi WJ; Oh KW; Koh SH; Ki CS; Kim SH
Neurobiol Aging; 2013 Apr; 34(4):1311.e7-9. PubMed ID: 23088937
[TBL] [Abstract][Full Text] [Related]
20. Utility of transcranial magnetic stimulation in delineating amyotrophic lateral sclerosis pathophysiology.
Vucic S; Kiernan MC
Handb Clin Neurol; 2013; 116():561-75. PubMed ID: 24112924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
